LENZ Therapeutics, Inc.
LENZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $20 | $35 | $44 | $18 |
| Short-Term Investments | $189 | $31 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $1 | $2 | $0 |
| Total Curr. Assets | $212 | $67 | $47 | $18 |
| Property Plant & Equip (Net) | $2 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $3 | $0 | $0 |
| Total NC Assets | $3 | $3 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $215 | $70 | $47 | $18 |
| Liabilities | – | – | – | – |
| Payables | $4 | $6 | $5 | $0 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $6 | $13 | $4 | $1 |
| Total Curr. Liab. | $10 | $19 | $9 | $1 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $144 | $61 | $31 |
| Total NC Liab. | $1 | $145 | $62 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $11 | $163 | $71 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$145 | -$95 | -$25 | -$14 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $349 | $3 | $1 | $0 |
| Total Equity | $204 | -$93 | -$24 | -$14 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $215 | $70 | $47 | $18 |
| Net Debt | -$19 | -$35 | -$44 | -$18 |